Stock technical analysis
Search documents
Avis Budget Stock Is Dipping Today: What's Going On?
Benzinga· 2026-03-27 14:35
Avis Budget Gr stock is holding steady today. Where is CAR stock headed?Airport Chaos Creates Rental‑Car DemandTravelers across the U.S. are facing hours‑long security lines as reduced TSA staffing slows airport operations, according to Bloomberg. With air travel becoming increasingly unreliable, investors are betting that more people will choose to drive and rent cars rather than risk missing flights."As check‑in lines grow at airports, car rental companies should see a bump as travelers look for alternati ...
FDA Review Puts Rezolute's Genetic Disorder Drug Path In Question
Benzinga· 2026-03-24 18:00
In a recent update, Rezolute shared insights from its March 17 meeting with the FDA regarding its Phase 3 sunRIZE trial for ersodetug, aimed at treating congenital hyperinsulinism.FDA Meeting Highlights Mixed Efficacy Signals In SunRIZE TrialThe company reported that while the primary endpoint was not statistically significant, there were clinically meaningful improvements in hypoglycemia events as measured by continuous glucose monitoring.The FDA acknowledged the challenges posed by behavioral factors in c ...
Why Milestone Pharma Stock Is Taking A Dive Today
Benzinga· 2026-03-20 15:40
• Milestone Pharmaceuticals stock is taking a hit today. Why is MIST stock falling?European Decision Timeline PushedIn January, the European Medicines Agency accepted the marketing application for etripamil in paroxysmal supraventricular tachycardia (PSVT), supported by the same global data package used for FDA approval in December 2025.PSVT is a type of arrhythmia (irregular heartbeat) characterized by sudden, sporadic bursts of a rapid, regular heart rate (120–230 bpm) that start and stop abruptly.The co ...
What's Going On With Aldeyra Therapeutics Stock On Thursday?
Benzinga· 2026-03-19 13:01
Since Tuesday, the company’s stock has slumped by around 67%.FDA Rejects Aldeyra Reproxalap ApplicationThe company received an FDA Complete Response Letter (CRL) for its New Drug Application for reproxalap, indicating a lack of substantial evidence from controlled studies.The FDA’s letter raised concerns over the efficacy of reproxalap, stating that further trials are not recommended, but suggested exploring specific populations where the drug may be effective.In a statement, Aldeyra’s CEO emphasized the ur ...
What's Going On With Kraft Heinz Stock Today?
Benzinga· 2026-03-18 19:12
The Kraft Heinz Company (NASDAQ:KHC) shares are down on Wednesday while the broader markets are experiencing declines.The company has entered a five-year global partnership with the National Football League, marking Kraft Heinz as the NFL’s first-ever global condiment partner, which is expected to enhance fan engagement and food experiences. The partnership aims to integrate Kraft Heinz’s extensive portfolio of iconic brands with the NFL’s vast audience, unlocking premium visibility at stadiums and during m ...
MicroStrategy Stock Price Faces New Risk as Institutional Investors Pull Back
Yahoo Finance· 2026-02-23 14:25
Core Viewpoint - MicroStrategy's stock price has rebounded nearly 30% from its February 5 low but remains under pressure due to institutional selling and technical resistance, with the stock down about 19% over the past month and over 60% in the last three months [1][2]. Institutional Selling - Recent 13F filings indicate a significant trend of institutional investors reducing or completely exiting their positions in MicroStrategy, with firms like Angeles Wealth Management and Wealth Watch Advisors cutting their holdings by 100% [5][6]. - Other notable reductions include Caitlin John LLC decreasing its position by 96.54%, Kovitz Investment Group reducing its share count by 19.31% (with a nearly 62% drop in value), and Atomi Financial Group cutting exposure by 18.61% (with a position value drop of over 61%) [6][7][8]. - Even firms that increased their holdings, such as Invesco (up 14.12%), experienced a total investment value decline of over 46% [8]. Technical Indicators - The stock's technical structure shows a hidden bearish divergence, with a lower high formed in the stock price while the Relative Strength Index (RSI) indicated a higher high, suggesting weakening momentum [9]. - Declining volume indicators further imply that the support for the recent recovery may not be strong, indicating a lack of conviction among remaining investors [11].
Wendy's Stock Pulls Back Friday After Activist Spark
Benzinga· 2026-02-20 17:09
Core Insights - Wendy's shares have declined significantly due to disappointing 2026 guidance, with projected adjusted EPS of 56 to 60 cents, falling short of the 86-cent consensus, and a forecast of flat global sales [2] - The stock has reached a new 52-week low, reflecting a sharp repricing driven by weak earnings power and modest growth expectations [3] Financial Performance - The company reported a double-digit decline in U.S. same-restaurant sales and shrinking company-operated margins, contributing to investor concerns [2] - Over the past 12 months, shares have decreased by 47.64%, indicating ongoing weakness in the stock [6] Market Sentiment - Trian has suggested that Wendy's shares are undervalued and has proposed potential strategic moves, including acquisitions that could lead to a de-listing of shares [4] - The market has seen a mixed technical outlook, with the stock trading 1.4% above its 20-day simple moving average but 5.5% below its 100-day simple moving average [6] Stock Analysis - The Relative Strength Index (RSI) is at 55.63, indicating a neutral position, while the MACD shows a bullish signal, suggesting mixed momentum in the stock [7] - Key resistance for the stock is identified at $9.00 [7] Recent Price Action - As of the latest publication, Wendy's shares were down 4.93% at $7.91 [8]
Market expert warns Tesla stock could crash to $217
Finbold· 2026-02-17 12:32
Core Viewpoint - Tesla stock is nearing a critical technical inflection point, with $399 identified as a key support level that could determine the stock's stability or lead to a deeper correction [1][2]. Technical Analysis - A decisive break below $399 could expose Tesla stock to lower technical targets at $325, $266, and $217 [2]. - The year-to-date decline of 4.71% is considered modest, especially in light of negative sales forecasts for 2025 and poor vehicle registration figures in Europe [3][5]. - Tesla's stock is currently up 17.88% over the past 12 months, despite challenges faced in the business environment [9]. Market Context - The electric vehicle industry is experiencing a broad slowdown, with significant declines reported by other major companies, such as BYD in China [8]. - Elon Musk's relationship with the Trump administration has negatively impacted sales in Europe and could affect the U.S. market as well [7]. Investor Sentiment - Despite the potential risks, Tesla has managed to avoid catastrophic crashes, indicating a level of resilience in its stock performance [2].
200 Years Later, This Stock Is Still Setting New All-Time Highs
Yahoo Finance· 2026-02-12 16:25
Core Viewpoint - Citizens Financial (CFG) is experiencing strong performance with significant stock appreciation and positive analyst sentiment, indicating a favorable investment opportunity in the retail banking sector [2][6]. Company Overview - Established in 1828, Citizens Financial is valued at $28.7 billion and is one of the largest retail bank holding companies in the U.S. [1] - The company offers a range of retail and commercial banking products and services across New England, Mid-Atlantic, and Midwest regions [1]. Stock Performance - CFG shares have increased by 45% over the past year and are currently trading at $65.20, with a recent all-time high of $68.79 [6][7]. - The stock has shown strong technical momentum, maintaining a 100% "Buy" opinion from Barchart, and has gained 11.2% over the past month [6][7]. Technical Indicators - CFG has a Weighted Alpha of +53.56 and a Relative Strength Index (RSI) of 57.12, indicating strong momentum [7]. - The stock's 50-day moving average is $60.98, with a technical support level around $65.71 [7]. Financial Projections - Revenue and earnings are expected to grow by 32.60% this year and an additional 22.97% next year [8]. - The stock has a trailing price-earnings ratio of 17.45x and a dividend yield of 2.77% [7][8].
Firefly Aerospace Stock Drops On SpaceX-Tesla Merger Speculation - Firefly Aerospace (NASDAQ:FLY)
Benzinga· 2026-01-30 14:38
Core Viewpoint - Firefly Aerospace Inc. shares have declined amid speculation regarding potential merger discussions between Tesla and SpaceX, despite a year-to-date increase of over 13% [1][2][3]. Company Performance - Firefly shares are currently trading significantly below their $45 debut price but are favored by traders due to their inclusion in the Russell 2000 and a growing defense backlog [3]. - The company is preparing for the Blue Ghost Mission 2 lunar landing and the development of the medium-lift Eclipse rocket, which are key upcoming events for investors [3]. Technical Analysis - The stock is trading 6.2% below its 20-day simple moving average (SMA) and 3% below its 100-day SMA, indicating short-term weakness while maintaining some longer-term strength [4]. - The stock is closer to its 52-week lows, suggesting a bearish trend [4]. Momentum Indicators - The Relative Strength Index (RSI) is at 50.12, indicating neutral territory, while the Moving Average Convergence Divergence (MACD) is below its signal line, suggesting bearish pressure [5]. - This combination of indicators suggests mixed momentum, advising caution among traders [5]. Earnings & Analyst Outlook - The next earnings report is anticipated on March 22, which could provide further insights into the company's performance [6]. - The stock carries a Buy Rating with an average price target of $40.75, despite recent declines [7]. Price Action - Firefly closed at $27.09, down 6.13% on Thursday, and further declined by 1.07% to $26.80 in Friday's pre-market session [7]. - Key resistance is identified at $28.50 and key support at $21.50 [9].